Clinical and Translational Imaging Q3 Unclaimed
This journal covers clinical practice and translational research and clinical applications of approved and experimental radiopharmaceuticals for diagnostic and therapeutic purposes, benefiting a wide readership of nuclear medicine and allied professionals.The journal complies with ethical guidelines, authors have to declare any Conflict of Interest in detail. Authors must also state that they conformed with the Helsinki Declaration of 1975 concerning Human and Animal Rights, and that they followed out policy concerning Informed Consent. Further details about the ethical policies are available under """"Ethics & Disclosure"""".This is the journal of the Italian Association of Nuclear Medicine (AIMN). AIMN members have free access to the journal. The journal’s field is molecular imaging using technologies ranging from morphological to functional and in vivo biochemical imaging. It offers a comprehensive overview of validated applications and optimisation of use of imaging procedures. It may also deal with radiation physics and biology and pharmacokinetics applied to translational and clinical imaging. The journal targets clinical practitioners and professionals involved in preclinical development of molecular imaging for application in human subjects. It has an SJR impact factor of 0,457.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3060 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,457
SJR Impact factor36
H Index65
Total Docs (Last Year)160
Total Docs (3 years)2981
Total Refs291
Total Cites (3 years)129
Citable Docs (3 years)2.01
Cites/Doc (2 years)45.86
Ref/DocOther journals with similar parameters
Topics in Magnetic Resonance Imaging Q3
Neuroradiology Journal Q3
Techniques in Vascular and Interventional Radiology Q3
International Journal of Molecular Imaging Q3
Journal of Echocardiography Q3
Compare this journals
Aims and Scope
Best articles by citations
Lung scintigraphy in the diagnosis of pulmonary embolism: pathophysiological and practical evidence
View moreInnervation imaging in arrhythmia and arrhythmogenic disease
View moreAmyloid PET imaging: a challenge for research in clinical neuroimaging
View moreThe new era of cancer immunotherapy: what can molecular imaging do to help?
View moreHybrid tracers and devices for intraoperative imaging: the future for radioguided surgery?
View moreIntegrative PET: a new concept for outcome prediction in lymphoma
View more123I-Metaiodobenzylguanidine cardiac innervation imaging: methods and interpretation
View morePET/MRI and brain tumors: focus on radiation oncology treatment planning
View moreSPET-CT in thyroid cancer: a systematic review
View moreHTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer
View moreRadiomics in PET: principles and applications
View moreIntegration of imaging biomarkers into systems biomedicine: a renaissance for medical imaging
View moreAssessment of response to treatment in paediatric bone sarcomas by means of PET imaging
View moreFuture trends in prostate cancer theranostics with PSMA ligands
View moreSuperparamagnetic iron oxide nanoparticles as a multimodal contrast agent for up to five imaging modalities
View moreFDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma
View moreHead and neck cancer: towards a new paradigm with sentinel node localization
View moreCurrent status of FDG-PET/CT in the treatment setting of Hodgkin's lymphoma in childhood and adolescence
View moreErratum to: Amino acid PET and MR perfusion imaging in brain tumours
View moreThe role of iodine-124 positron emission tomography in molecular imaging
View moreThe eye of nuclear medicine
View moreRadiopharmacology and molecular imaging of PD-L1 expression in cancer
View moreWhole-body PET/MRI in oncology: current status and clinical applications
View moreThe role of F-18-fluorothymidine PET in oncology
View more
Comments